Darling Ingredients continues to struggle despite long-term tailwinds, as short-term economics remain deeply unfavorable.

Q2 2025 Earnings Call Transcript July 31, 2025 Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...